Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

Saved in:
Bibliographic Details
Title: Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.
Authors: Mellinghoff SC; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Liss B; Department of Hematology, Oncology, Infectious Disease, and Palliative Care, Helios University Hospital Wuppertal, Wuppertal, Germany; School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany., Stemler J; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Petzer V; University Hospital of Internal Medicine V Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Egger-Heidrich K; Medical Department I, Division of Hematology, Cell Therapy, and Medical Oncology, University Hospital Carl Gustav Carus, Dresden, Germany; DKMS Clinical Trials Unit, DKMS Group, Dresden, Germany., Monin MB; Department of Hematology, Oncology, and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Christopeit M; Department of Hematology, Oncology, and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Giesen N; Department of Hematology, Oncology, and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany; Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany., Keppler-Hafkemeyer A; Department of Medicine I, Medical Centre-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Hattenhauer T; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Heinz WJ; Medical Clinic II, Caritas Hospital, Bad Mergentheim, Germany., Khatamzas E; Department of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany., Maschmeyer G; Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany., Mispelbaum R; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Steinke J; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany., Richardson T; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany., Sprute R; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Cornely OA; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Clinical Trials Centre Cologne, Germany; University of Cologne, Cologne, Germany., Rieger CT; Hematology Oncology Germering, Germering, Germany; University of Munich, Munich, Germany. Electronic address: agiho@dgho.de.
Corporate Authors: German Society of Hematology and Medical Oncology Infectious Diseases Working Group (AGIHO)
Source: The Lancet. Oncology [Lancet Oncol] 2026 Apr; Vol. 27 (4), pp. e195-e206.
Publication Type: Journal Article; Practice Guideline; Review
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(25)00765-X